Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Cagrilintide is a long-acting acylated amylin analog developed by Novo Nordisk. It is investigational and not FDA-approved; Novo Nordisk's lead development path is the CagriSema co-formulation with semaglutide for weight management. Monotherapy cagrilintide was evaluated in Phase 2 but was deprioritized in favor of the combination.
2 of 13 vendors lab-verified
Verified purity per dollar — the cheapest that's actually been tested
vial · 10mg· ngpeptide.com· price updated today
$65.00✓ $6.50/mg
single-vial price — packs may be lower
vial · 10mg· peptidesupplyco.com· price updated today
Lot CGL1006032026· tested 2026-06-08
$85.00✓ $8.50/mg
24% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· ionpeptide.com· price updated today
$99.00✓ $9.90/mg
34% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· glacieraminos.shop· price updated today
$101.99✓ $10.20/mg
36% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· orbitrexpeptide.is· price updated today
$99.99✓ $10.00/mg
35% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· moglabs.bio· price updated today
$82.00✓ $8.20/mg
21% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· profoundaminos.com· price updated today
$98.00✓ $9.80/mg
34% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· skyepeptides.com· price updated today
$149.00✓ $14.90/mg
56% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· simplepeptide.com· price updated today
$140.00✓ $14.00/mg
54% more per mg vs cheapest
single-vial price — packs may be lower
vial · 5mg· optimasupply.is· price updated today
$150.00−33%
$100.00✓ $20.00/mg
68% more per mg vs cheapest
single-vial price — packs may be lower
vial · 5mg· realpeptides.co· price updated today
$160.00✓ $32.00/mg
80% more per mg vs cheapest
single-vial price — packs may be lower
vial · 5mg· biolongevitylabs.com· price updated today
$170.00✓ $34.00/mg
81% more per mg vs cheapest
single-vial price — packs may be lower
vial · 10mg· peptidetech.is· price updated today
$59.99$6.00/mg
single-vial price — packs may be lower
vial · 5mg· crushresearch.shop· ⚠ price updated 1mo ago
$49.67$9.93/mg
single-vial price — packs may be lower
23 vendors not shown — trust grade below C, or not enough verified COA data yet. We only list sources with a C grade or better.
Best price trend
Lowest $/mg for Cagrilintide · verified listings only
$6.50/mg
▼ 27% over 90d
Peptide Tech has the lowest single-vial Cagrilintide price at $6.00/mg among 27 COA-verified vendors on Disclosed Labs. Bulk or multi-vial deals may be lower. That's 82% less per mg than the most expensive option.
What is the price range for Cagrilintide?
Research-grade Cagrilintide ranges from $6.00/mg to $34.00/mg across 14 verified sources, a 82% spread per mg.
How are Cagrilintide prices verified on Disclosed Labs?
Every listed vendor holds a Grade C or better trust score, computed independently from lab Certificates of Analysis — not from payments or sponsorships. Prices are scraped and fact-checked daily. Vendors cannot pay to improve their ranking.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Use the Full safety panel filter to require endotoxin, sterility, and heavy-metals testing on the current batch — not just HPLC purity.
A Phase 2 dose-finding trial of cagrilintide monotherapy demonstrated dose-dependent weight loss of up to 10.8% over 26 weeks versus 3.0% for placebo (Lau et al., The Lancet, 2021). Novo Nordisk pivoted development to the CagriSema co-formulation with semaglutide 2.4 mg. The Phase 3 REDEFINE 1 trial (n=3,417, 68 weeks) in obesity reported ~22.7% mean body weight reduction on the treatment-policy estimand, with 91.9% achieving ≥5% weight loss versus 31.5% for placebo. Novo Nordisk submitted a CagriSema NDA to the FDA in December 2025; the application is under review in 2026. Cagrilintide is not FDA-approved as a standalone therapy, and CagriSema is not yet approved as of April 2026.
This platform provides informational tools only, not medical advice.
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
2021
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management
2021
Prices verified as of July 2026. Actual prices may vary. For research use only.
Single-vial list prices by default for a fair head-to-head — switch to Multi-vial / bulk for pack pricing. Estimates only; verify at vendor before purchase. For research use only. Not medical advice.
Disclosed Labs